Nuvig Therapeutics is advancing transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis and rebalance immune function in autoimmune and chronic inflammation diseases.

Revolutionizing intraoperative histology with their NIO Laser Imaging System and AI-powered image analysis.

Mediar Therapeutics is drugging the myofibroblast as a new approach to halt and reverse fibrosis. 

Jupiter Bioventures LLC is a company creation engine – focused on de-risking early-stage projects.

Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products.

Kit offers comprehensive at-home health & lab testing solutions.

Zag Bio is working to discover and develop therapies targeted directly to the thymus, with the goal of generating central immune tolerance.

March Bio is a clinical stage company advancing novel cell therapies for T-cell malignancies.

Ribonaut Therapeutics is a stealth company developing therapeutics for undruggable targets.

Eikonizo is developing brain penetrant and peripherally-restricted small molecule HDAC6 inhibitors to improve the treatment of human disease.

Unlocking the power of plants to create the next generation of animal-based food substitutes.

CAVALRY Biosciences is developing novel therapeutics by engineering tissue-selective growth factors and cytokines to harness their potent biology and build better treatments for both rare and chronic diseases.

Founded by Mission BioCapital, Arclight is building a portfolio of neurodegeneration companies to accelerate transformative neuroscience.

Bolt Threads is a material solutions company inspired by nature to develop materials for a more sustainable future. 

Progentos is developing a new approach to treating multiple sclerosis that stimulates the body’s natural repair mechanisms.

QurAlis is developing breakthrough precision medicines for ALS and other neurologic diseases.

Ambagon is drugging the undruggable by manipulating interactions with the adaptor protein 14-3-3.

Epiodyne is developing breakthrough medicines to provide patients with safe options to break their opioid dependence, fight the spread of opioid use disorders, and provide non-addictive pain relief.

Applaud Medical aims to improve treatment methods, patient experiences and medical costs for all patients experiencing the effects of kidney stones.

Circle Pharma operates an indication-agnostic discovery engine for the development of cell permeable macrocyclic peptide therapeutics.

Volnay is building transformative and commercially viable cell and gene ventures centered on product development and technology innovation.

Myka Labs is pioneering a magnetic and minimally invasive surgical device to allow complex GI tract interventions.

ARase Therapeutics is developing first-in-class inhibitors that target cancer signaling pathways.

Leveraging proprietary microbiome research to develop products that naturally promote the clarity, vibrance, and resilience of skin.

Vaxess Technologies is transforming delivery of vaccines and therapeutics through the MIMIX patch, making vaccines more effective and accessible. 

Nocion Therapeutics is revolutionizing the treatment of neurogenic inflammation by silencing inflamed nociceptors. 

Vivace Therapeutics is an oncology-focused small molecule drug discovery and development company.

Avexegen is developing novel therapies to promote and restore gut health.

Starting with sushi-grade salmon, Wildtype is pioneering cellular agriculture to grow delicious cuts of our favorite seafood.

Fluxion Biosciences develops microfluidic tools for cellular analysis and liquid biopsy tests.

AI Proteins is a biotech company on a mission to re-imagine protein therapeutics with a novel approach for designing entirely new proteins. Using AI-enabled design and a high-throughput drug discovery platform, AI Proteins creates de novo miniproteins optimized for a variety of therapeutic applications.

Sound Agriculture is creating a more agile and resilient food system with innovative on-demand crop solutions.

Founded by Mission BioCapital, Arclight is building a portfolio of neurodegeneration companies to accelerate transformative neuroscience.

ImmunOs Therapeutics is developing the next generation of immunomodulatory therapies that have a role in the innate immune system for cancer and autoimmune diseases.

Symic Biomedical is developing therapeutics for fibrotic diseases by targeting the extracellular matrix.

Shape Therapeutics is harnessing the potential of RNA therapeutics to shape the future of gene therapy.  

LogicInk is a lifestyle sensor company, developing bio-chemical Signals that can be worn or applied daily.

Magnap is developing a minimally-invasive surgical device to prevent airway collapse during sleep.

Sensorium Therapeutics is a clinical stage biotechnology company developing brain and mental health treatments that are derived from nature, mechanistically driven, clinically precise, and designed to help people thrive.

Developing therapies for patients with rare diseases of  protein and lipid glycosylation. 

Developing a new class of medicines based on breakthrough discoveries in enzyme biology.

Tune Therapeutics is developing next-generation cell-therapies using their platform of targeted epigenetic modifiers.

Tangible Science is committed to creating products to make a more comfortable contact lens.

Alessa Therapeutics is focused on development, clinical validation and commercialization of local, sustained drug delivery for solid tumors. 

PanTher is developing treatments for solid tumors through minimally invasive implantable modalities for localized cancer therapy. 

Developing antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.